Seeing Is Believing
Currently out of the existing stock ratings of Zhiqiang Shu, 18 are a BUY (72%), 7 are a HOLD (28%).
Analyst Zhiqiang Shu works with a stock forecast success ratio of 33.33% fulfilled within 45.22 days on average. Previously, Zhiqiang Shu worked at BERENBERG.
Zhiqiang Shu’s has documented 44 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BPMC, Blueprint Medicines Corp at 13-Sep-2023.
Analyst best performing recommendations are on BLUE (BLUEBIRD BIO).
The best stock recommendation documented was for BLUE (BLUEBIRD BIO) at 11/12/2021. The price target of $11 was fulfilled within 6 days with a profit of $0.68 (5.82%) receiving and performance score of 9.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
3
$1.84 (158.62%)
5
28 days ago
2/5 (40%)
$1.63 (118.98%)
178
Hold
6
$4.84 (417.24%)
8
28 days ago
1/5 (20%)
$4.63 (337.96%)
24
Buy
7
$5.84 (503.45%)
10
4 months 12 days ago
0/2 (0%)
$4.21 (150.90%)
Buy
12
$10.84 (934.48%)
11
4 months 13 days ago
1/8 (12.5%)
$8.93 (290.88%)
184
Buy
13
$11.84 (1020.69%)
10
5 months 16 days ago
4/7 (57.14%)
$9.74 (298.77%)
106
What Year was the first public recommendation made by Zhiqiang Shu?